Gene control goals

How Camp4’s computational platform identifies druggable targets that control disease genes

By mapping all of the signaling pathways and transcription factors that control the expression of every gene in a cell type of interest, Camp4 Therapeutics Corp. is betting its machine learning-based platform will be able to identify druggable targets that can control gene expression without the need for physical target screening.

According to CEO Josh Mandel-Brehm, many genetic diseases could be treated by adjusting the expression

Read the full 653 word article

How to gain access

Continue reading with a
two-week free trial.